Acceptability of compounded preparations - A Romanian pediatric hospital perspective

Corina Briciu1, Daniel Leucuța2, Adina Popa1

  • 1"Iuliu Hațieganu" University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Clinical Pharmacy, Cluj-Napoca, Romania.

Insights

Children

Area of Science:

  • Pediatric Pharmacology
  • Pharmaceutical Compounding
  • Patient Acceptability Studies

Background:

  • Compounded medicines are frequently prescribed for pediatric patients.
  • Understanding children's acceptance of these preparations is crucial for treatment adherence.
  • Limited data exists on compounding practices and acceptability in Romanian pediatric settings.

Purpose of the Study:

  • To assess the acceptability of compounded medications among pediatric patients in Romania.
  • To identify characteristics of compounding practices influencing acceptability.
  • To provide insights for improving pediatric medication adherence.

Main Methods:

  • Observational, cross-sectional, and retrospective study in three pediatric departments.
  • Inclusion of patients under 18 years using compounded medications.
  • Data collection via interviewer-administered questionnaires and a 3-point facial hedonic scale for acceptability.

Main Results:

  • 162 compounded medications were evaluated.
  • Acceptability varied by dosage form: oral (20.83% positive), oromucosal (20.63% positive), and cutaneous (66.67% positive).
  • Despite some disapproval, medication administration was successful in over 75% of cases.

Conclusions:

  • Factors like ease of swallowing, capsule form, and administration method impact oral compounded medication acceptability.
  • Improving compounded preparation acceptability is key to enhancing pediatric treatment outcomes.
  • This study provides valuable data for Romanian pediatric compounding practices.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
184
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
983
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
237
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.9K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
463